INTRODUCTION
Sphingomyelin is a major lipid constituent of animal cell membranes, including plasma membranes, myelin sheath and erythrocyte stroma. It is degraded in lysosomes by acid sphingomyelinase (sphingomyelin phosphodiesterase; EC 3.1.4.12) yielding phosphorylcholine and ceramide. Abnormalities in sphingomyelin metabolism have been found in atherosclerosis, cancer and a genetically transmitted disease, namely Niemann-Pick disease [1] . With the exception of Niemann-Pick disease, the underlying causes of these abnormalities are not known. Niemann-Pick disease is a group of inherited metabolic diseases, which are characterized by abnormal accumulation of sphingomyelin in patients' tissues. Several types of this disease, classified according to clinical, pathological, and biochemical criteria, are known. In the most recent classification, Spence and Callahan [2] separated this group of diseases into two types. Type I includes three subgroups all of which are caused by sphingomyelinase deficiency. Type II also includes three subgroups in which the primary defect is not known.
All saposins (A, B, C and D) are produced by partial proteolysis of a single precursor protein, prosaposin, and are involved in lysosomal hydrolysis of many sphingolipids [3] . We have previously shown that saposin D stimulates acid sphingomyelinase activity of a human placenta preparation [4] and that abnormal accumulation of saposin D, and other saposins to a lesser extent, occurs in tissues of patients with Niemann-Pick disease [5] . Stimulation of sphingomyelinase by a saposin C preparation has been reported previously [6] [7] [8] , but possible contamination of the preparations involved by saposin D was not excluded. These findings suggest that saposin D may be involved in the mechanism latory to inhibitory. Conversely, when the detergent is added to the purified enzyme, the effect of saposin D on sphingomyelinase activity changed from being inhibitory to stimulatory. While other saposins were inhibitory or had no effect on sphingomyelinase activity in the above assay system, not only saposin D but also saposins A and C exhibited a stimulatory effect upon purified sphingomyelinase activity when the substrate, sphingomyelin, was added in the form of liposomes without detergent. Saposin B was not only inhibitory in the liposome system, but also reduced the stimulatory effect of saposins A, C and D. These observations indicate that the stimulatory effect of saposins A, C and D on acid sphingomyelinase activity is greatly influenced by the physical environment of the enzyme and suggest that similar effects by saposins may be exerted in lysosomal membranes.
of this genetic disease, especially in the Type II phenotype, in which patients have apparently normal in vitro sphingomyelinase activity.
In addition to its clinical importance, saposin D may also be involved in controlling sphingomyelin turnover in animal tissues. A significant link between sphingomyelin turnover and protein kinase C has been suggested [1, 9] . Since saposin D may be involved in controlling sphingomyelinase activity in tissues, it may be playing a significant role in producing important secondary messengers, namely ceramide, sphingosine, and choline, the compounds produced by the hydrolysis of sphingomyelin. The present investigation was undertaken to further characterize the stimulatory effect of saposin D and the other saposins on sphingomyelinase activity in order to understand its role in sphingomyelin metabolism in tissues.
MATERIALS AND METHODS
Sphingomyelinase assay with sphingomyelin in micelles The assay was performed as described previously using [cholinemethyl-14C]sphingomyelin (830 c.p.m./nmol) as the substrate [4] . Additional Triton X-100 (Calbiochem) was added when needed, as described in specific experiments. A Triton X-100 extract of a particulate fraction of human kidney, prepared as described previously [4] , was used as the crude enzyme preparation. A purified acid sphingomyelinase preparation was prepared from human placenta as described previously [10] . As estimated from SDS/PAGE, this preparation was approx. 50 lOl. After shaki 2 h, 0.3 ml of water and 1.5 ml of chloroform/r v/v) were added, mixed, and centrifuged. This ass not contain Triton X-100. An aliquot (0.5 ml) (aqueous) layer was counted for radioactivity.
Saposins
Saposins A, C, and D were isolated from Gau described previously [4, 5] .'y mituConsistent with the previous observations using the crude aofmxtueupdd human placental preparation [4] , addition of saposin D stimulated acid sphingomyelinase activity in the crude preparation from human kidney (Figure 1 ). The results of kinetic studies indicate that saposin D increases both the apparent Km value for sphingomyelin, from 0.05 mM to 0.5 mM, and the Vm.. value, from 0.1 nmol/h to 1.0 nmol/h. cher spleen as Unlike the crude enzyme preparations, saposin D strongly trified from the inhibited the sphingomyelinase activity of the highly purified M. Hiraiwa, S. enzyme preparation from human placenta (Figure 1 One of the significant differences between the crude and purified enzyme preparations is the presence of Triton X-100. While 10 ,ul of the crude preparation (the amount routinely used for each assay) contained about 36,ug of Triton X-100, the purified preparation did not contain detergent. Therefore, we tested the effect of various concentrations of this detergent on the sphingomyelinase assay. The activity of both crude and purified sphingomyelinase in the absence of saposin D was highly dependent upon the amount of Triton X-100 added (Figure 2 ). varying the amount of saposin D on the purified enzyme activity in the presence of this concentration of Triton X-100 was tested. Under these conditions, the addition of saposin D increased the enzyme activity at levels up to 1 ,tg/assay and then the degree of stimulation decreased slowly with increasing saposin D concentrations.
Since Triton X-100 variably affected the saposin D effect, the activity of sphingomyelinase was investigated by using the substrate in liposomes which contained no detergent as described by Poulos et al. [11] . The activity was increased by the addition of saposin D reaching a maximum (10-fold higher than that of the control) at a concentration of 3 ,M and then declined, as shown in Figure 4 Table 1 .
Acid sphingomyelinase is a glycoprotein strongly bound to the lysosomal membrane [2] . Its activity in vitro is highly dependent on the addition of a detergent or phospholipids, indicating that the membrane form is essential to exert its enzymic activity. The present investigation demonstrates that the sphingomyelinase activity in vitro is activated or inhibited by not only saposin D, as shown in our previous publication [4] , but also by the other saposins A, B and C depending upon the composition of the micelle or liposome. We found that saposin D was inhibitory at low concentrations of Triton X-100 but became stimulatory at 0.04% or higher Triton X-100 concentrations. Under these conditions, other saposins (A, B, and C) were either inhibitory or had no effect on sphingomyelinase activity. On the other hand, when the substrate was presented in the form of liposomes without Triton X-100, all saposins, except saposin B, stimulated the sphingomyelinase activity to a significant degree. These observations suggest that similar modulation of sphingo-myelinase activity may be occurring in tissues. Whether these saposins stimulate the spingomyelinase activity by interacting with the enzyme or substrate, or by simply changing micellar or liposomal nature, is to be investigated.
